Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid Cancer
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae667 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Sonia Moretti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Internal Medicine and Endocrine and Metabolic Sciences, Department of Medicine and Surgery, University of Perugia, Perugia 06132, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Tumor Suppressor Protein p53, Mutation, Wnt Signaling Pathway. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: "Fondazione Brunello e Federica Cucinelli"-Corciano, Perugia, Ministero dell'Istruzione, dell'Università e della Ricerca, “Fondazione Brunello e Federica Cucinelli”—Corciano, Perugia.
Abstract (Originalsprache)
Context
Anaplastic thyroid carcinomas (ATCs) and poorly differentiated thyroid carcinomas (PDTCs) exhibit distinct immune-related gene expression profiles. Most ATCs are characterized by active immune interactions (hot or altered immunosuppressed immunophenotypes), while PDTCs are largely immunologically inert (cold immunophenotypes).
Objective
This study aimed to elucidate the mechanisms driving these divergent immunological fates, focusing on the Wnt/β-catenin pathway and TP53 mutations.
Results
Our data reveal that ATCs frequently harbor TP53 mutations (83.3%), which correlate with a hot immunophenotype, characterized by high expression of β-catenin-regulated cytokine CCL4 and recruitment of CD103 + dendritic cells. Conversely, PDTCs, with a lower incidence of TP53 mutations (12.5%), often exhibit a cold immunophenotype. In cold cancers and PDTCs, β-catenin is overexpressed, suggesting that Wnt/β-catenin pathway activation drives immune exclusion through CCL4 downregulation. Further analysis indicated that loss of p53 function is inversely correlated with β-catenin expression. P53-mutated cancers showed significantly higher expression of CCL4 and densities of CD103 + dendritic cells compared to their p53-wild-type counterparts. Additionally, p53-mutated ATCs expressed a higher number of immune-related genes, supporting the role of p53 loss in activating immune responses in cancer.
Conclusion
Our study indicates a potential correlation between the activation of the Wnt/β-catenin pathway and the development of cold thyroid cancers, which may be mediated by the suppression of CCL4 expression. Concurrently, mutations in the p53 gene appear to be linked with the occurrence of hot thyroid cancers. While these associations are compelling, they are based on observational data. Experimental research is necessary to determine the causal relationships underlying these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Internal Medicine and Endocrine and Metabolic Sciences, Department of Medicine and Surgery, University of Perugia, Perugia 06132, Italy.
- Section of Anatomic Pathology and Histology, Department of Medicine and Surgery, University of Perugia, Perugia 06132, Italy.
- Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa 56126, Italy.
ORCID-Profile: Sonia Moretti, Fulvio Basolo, Efisio Puxeddu
Förderung
- "Fondazione Brunello e Federica Cucinelli"-Corciano, Perugia
- Ministero dell'Istruzione, dell'Università e della Ricerca
- “Fondazione Brunello e Federica Cucinelli”—Corciano, Perugia
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Moretti, S., Mandarano, M., Menicali, E., Guzzetti, M., Morelli, S., Talpacci, E., Colella, R., Bini, V., Giannini, R., Ugolini, C., Sidoni, A., Basolo, F., & Puxeddu, E. (2025). Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae667
Vancouver
Moretti S, Mandarano M, Menicali E, Guzzetti M, Morelli S, Talpacci E, et al. Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae667
BibTeX
@article{Moretti2025,
author = {Moretti, Sonia and Mandarano, Martina and Menicali, Elisa and Guzzetti, Martina and Morelli, Silvia and Talpacci, Edoardo and Colella, Renato and Bini, Vittorio and Giannini, Riccardo and Ugolini, Clara and Sidoni, Angelo and Basolo, Fulvio and Puxeddu, Efisio},
title = {Wnt/B-catenin Activation and TP53 Mutations Associate With Distinct Immune Profiles in Advanced Thyroid Cancer},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae667}
}
EUVIMED